Yuanyuan Zhao

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials

Wenfeng Fang, Yunpeng Yang, Yuxiang Ma et al. · The Lancet Oncology · 2018 · 507 citations

Medicine, Oncology, Pharmacology +13

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

Wenfeng Fang, Jianwei Zhang, Shaodong Hong et al. · Oncotarget · 2014 · 390 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

Li Zhang, Kenzie D. MacIsaac, Ting Zhou et al. · Molecular Cancer Research · 2017 · 218 citations

Medicine, Genetics, Oncology +17

Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)

Yunpeng Yang, Jianji Pan, Hui Wang et al. · Cancer Cell · 2023 · 215 citations · Full text

Medicine, Oncology, Pharmacology +17

Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With <i>EGFR</i> Variant

Wen‐Feng Fang, Yuanyuan Zhao, Yongzhong Luo et al. · JAMA · 2024 · 168 citations · Full text

Medicine, Oncology, Pharmacology +16